Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford and University Hospitals in Cleveland, Ohio, have announced a multi-year affiliation to establish a global centre for rare diseases.

The University of Oxford and University Hospitals in Cleveland, Ohio, have announced a multi-year affiliation to establish a global centre for rare diseases. The Oxford-Harrington Rare Disease Centre will bring together the capabilities, resources and expertise of both institutions to deliver new treatments for rare diseases, for which therapeutic options are lacking. In this partnership, the University of Oxford and Harrington Discovery Institute commit to addressing unmet need in rare disease. Through their combined resources, the new Centre will set the science and innovation agenda to support cutting-edge breakthroughs across the UK and US with the greatest chance for clinical impact.